Fifteen of 19 anti-ZIKV-IgM+ PNGMP reported clinical symptoms within the 4 weeks preceding blood sampling (Table 1), with six of them also reporting antibiotic and antimalarial treatment, highlighting the possibility of undetected ZIKV infection. Here, CD40LG is linked to Zika virus infectious disease.